IP Library Granted Patent US 11,021,453
Granted Patent B2
US 11,021,453 · App. 16/717,813 · Granted Jun 1, 2021

Carbamate compounds and methods of making and using same

Inventors: Justin S. Cisar (San Diego, CA); Cheryl A. Grice (Encinitas, CA); Todd K. Jones (Solana Beach, CA); Micah J. Niphakis (San Diego, CA); Jae Won Chang (San Diego, CA); Kenneth M. Lum (San Diego, CA); Benjamin F. Cravatt (San Diego, CA)
Assignees: LUNDBECK LA JOLLA RESEARCH CENTER, INC.; THE SCRIPPS RESEARCH INSTITUTE
C07D295/205A61P25/22C07C271/10C07C271/12C07D205/04C07D207/09C07D207/14C07D213/38C07D213/40C07D213/55C07D215/42C07D215/46C07D231/12C07D231/16C07D231/56C07D241/04C07D261/08C07D263/32C07D271/06C07D295/26C07D307/79C07D317/46C07D317/58C07D401/04C07D401/10C07D403/10C07D405/14C07D407/06C07D413/06C07D413/10C07D471/04C07D471/10C07D487/04C07D491/107
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,021,453
App. No.
16/717,813
Granted
Jun 1, 2021
Kind
B2
Abstract

This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for a method of treating a patient in need thereof, where the patient is suffering from post-traumatic stress disorder comprising administering a disclosed compound or composition.

Claims (1)

1. A method of treating post-traumatic stress disorder in a patient in need thereof, comprising administering to the patient an effective amount of 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate, or a pharmaceutically acceptable salt thereof.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 055679 FRAME: 0885. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 11, 2021
From: LUNDBECK LA JOLLA RESEARCH CENTER, INC.
To: H. LUNDBECK A/S
Reel/Frame 056544/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: LUNDBECK LA JOLLA RESEARCH CENTER, INC.
To: H. LUNDBECK A/S.
Reel/Frame 055679/0885 →
CHANGE OF NAME Recorded Jan 7, 2020
From: ABIDE THERAPEUTICS, INC.
To: LUNDBECK LA JOLLA RESEARCH CENTER, INC.
Reel/Frame 051437/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2019
From: NIPHAKIS, MICAH J.; CHANG, JAE WON; LUM, KENNETH M.; CRAVATT, BENJAMIN F.
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 051344/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2019
From: CISAR, JUSTIN S.; GRICE, CHERYL A.; JONES, TODD K.
To: ABIDE THERAPEUTICS, INC.
Reel/Frame 051349/0407 →
Continuity (5)
Continuation 15925517 · Mar 19, 2018
Continuation 15272313 · Sep 21, 2016
Continuation 14369982
Provisional Application 61631558 · Jan 6, 2012
Related Publication 20200270223A1 · Aug 27, 2020
Cited By (1)
US 12,286,421